《大行報告》中銀國際降京東健康(06618.HK)目標價至43元 逐漸遠離疫情噪音
中銀國際發表報告指,京東健康(06618.HK)去年下半年總收入按年持平達到264億元人民幣,與該行預期一致。截至去年12月底集團年活躍用戶數持續增長至1.73億戶,反映公司在品牌獲客和營運端的成果。毛利率達到21.4%,經調整淨利潤率達到6.4%,主要受益於強勁的利息收入。
中銀國際預計公司將會持續執行他們在商品供給的加強,價格體系的競爭力,醫療服務的豐富,醫療消費場景的拓展,品牌營銷,技術,全渠道和履約能力的提升的投資策略和力度,逐漸遠離疫情噪音。該行維持京東健康今明年收入及毛利的預測不變,然而下調利潤預測,主要由於上調的營運費用以及下調的利息收入導致。維持「買入」評級但削減目標價至43元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.